A pilot and feasibility analysis of serum TMAO and choline in a randomized sample from the COSMOS trial.
- 2025
- RCT · n = 40
- Food & function 16(22)
- Irene Sánchez Gavilán
- Sidong Li
- Michael G Sweet
- Juanita G Ratliff
- Pamela M Rist
- Eunjung Kim
- JoAnn E Manson
- Howard D Sesso
- Andrew P Neilson
- PubMed: 41127993
- DOI: 10.1039/d5fo02596f
- High evidence
- Rigorous Journal
- Elderly
those assigned to take a CE supplement, as compared to placebo, had similar TMAO and choline levels at baseline but showed trends toward lower levels of TMAO (-0.60 [95% CI, (-3.76, 2.55)]) at 1 year. However, the between-group differences in the 1 year changes in TMAO (CE minus placebo) were not statistically significant (-1.16 [95% CI, (-5.81, 3.50)]; P = 0.62).
- Effect
- Neutral
- Effect size
- Small
- Significant
- No
- Dose
- 500 mg/day flavanols